Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.8K Buy
1,121
+108
+11% +$2.87K ﹤0.01% 1512
2026
Q1
$27.2K Sell
1,013
-110
-10% -$3.3K ﹤0.01% 1486
2025
Q4
$34.6K Buy
1,123
+110
+11% +$3.43K ﹤0.01% 1366
2025
Q3
$31.1K Buy
1,013
+85
+9% +$2.07K ﹤0.01% 1308
2025
Q2
$19.2K Buy
928
+625
+206% +$12.8K ﹤0.01% 1388
2025
Q1
$5.93K Sell
303
-11
-4% -$231 ﹤0.01% 1710
2024
Q4
$6.55K Sell
314
-122
-28% -$2.68K ﹤0.01% 1613
2024
Q3
$10.6K Sell
436
-74
-15% -$1.98K ﹤0.01% 1459
2024
Q2
$12.8K Sell
510
-119
-19% -$3.37K ﹤0.01% 1217
2024
Q1
$18.8K Sell
629
-309
-33% -$9.08K ﹤0.01% 1101
2023
Q4
$29.9K Sell
938
-540
-37% -$17K ﹤0.01% 943
2023
Q3
$52.1K Buy
1,478
+1,036
+234% +$39.5K ﹤0.01% 826
2023
Q2
$16.8K Hold
442
﹤0.01% 1128
2023
Q1
$16.7K Buy
442
+328
+288% +$12.6K ﹤0.01% 1133
2022
Q4
$5K Sell
114
-200
-64% -$8.24K ﹤0.01% 1432
2022
Q3
$10K Sell
314
-15
-5% -$527 ﹤0.01% 1305
2022
Q2
$11K Sell
329
-220
-40% -$7.13K ﹤0.01% 1364
2022
Q1
$20K Buy
549
+24
+5% +$824 ﹤0.01% 1251
2021
Q4
$21K Buy
+525
New +$21.9K ﹤0.01% 1257

Other funds holding GMAB

UMB Bank's GMAB Position: Q2 2026 in Review

UMB Bank increased its Genmab (GMAB) stake by 11% in Q2 2026, buying an estimated $2.87K and bringing the position to 1,121 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

UMB Bank first reported a position in GMAB in Q4 2021 and has held it in 19 quarters since. The position peaked at $52.1K in Q3 2023. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • UMB Bank held 1,121 shares of Genmab worth $30.8K as of Q2 2026.
  • UMB Bank bought 108 Genmab shares in Q2 2026, an estimated $2.87K.
  • Genmab made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1512 holding.
  • UMB Bank first reported a position in Genmab in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Genmab position peaked at $52.1K in Q3 2023.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.